Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Collagen synthesis in connective tissue is a multi-step biosynthetic process primarily occurring in fibroblasts, involving gene transcription, translation, post-translational hydroxylation and glycosylation of pro-collagen polypeptides, assembly into triple-helical procollagen, secretion into the extracellular space, enzymatic removal of propeptides to produce tropocollagen, and cross-linking to form robust collagen fibrils. This process is critical for the structural integrity of tissues and is tightly regulated; its dysregulation is implicated in diseases such as fibrosis, scurvy, and genetic connective tissue disorders.
Cofactor supplementation (supports enzymatic steps); Enzyme inhibition (blocks post-translational modifications or cross-linking); Signaling pathway modulation (e.g., inhibition of TGF-beta to reduce fibrosis and collagen gene transcription)
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Collagen synthesis process.